ERG rearrangement is present in a subset of transition zone prostatic tumors

Sara M. Falzarano, Maria Navas, Kelly Simmerman, Eric A. Klein, Mark A. Rubin, Ming Zhou, Cristina Magi-Galluzzi

Research output: Contribution to journalArticle

49 Scopus citations

Abstract

A majority of prostate cancers exhibit a recurrent gene rearrangement involving chromosome 21. In approximately 90% of cases, the rearrangement is characterized by fusion of the androgen-regulated gene TMPRSS2 with the oncogene ERG. A recent study suggested that TMPRSS2-ERG gene fusion is lacking in cancers arising from the transition zone of the prostate. A dominant transition zone cancer was detected in 62/397 (16%) patients who underwent radical prostatectomy at our institution and were reviewed and mapped by a single pathologist. In 46/62 specimens, a secondary tumor was identified in the peripheral zone of the prostate. A tissue microarray containing both transition and peripheral zone tumors was constructed and evaluated for gene fusion analysis. TMPRSS2-ERG fusion status was determined using a multicolor interphase fluorescence in situ hybridization assay for ERG break-apart. The median age of the patients was 59 years. Prostatectomy Gleason score was 6 in 21, 7 in 34, and 8 in 7 cases. Median tumor volume was 200 mm 2. TMPRSS2-ERG gene fusion was present in 7/59 (12%) transition zone, and in 12/35 (34%) peripheral zone tumors. Transition zone fusion-positive cases were larger than their negative counterparts. No significant correlation was found between fusion status and Gleason score or pathologic stage. Gene fusion through deletion occurred in 4/7 transition zone and 7/12 peripheral zone tumors. Transition zone prostate cancers are considered biologically and genetically different from peripheral zone tumors. Although ERG rearrangement is more common in peripheral zone tumors, we have detected TMPRSS2-ERG fusion in a subset of transition zone cancers (12%). The lower frequency of gene fusion in transition zone prostate cancer may suggest distinct molecular alterations from peripheral zone tumors and the association with a high tumor volume may indicate a growth advantage for transition zone tumors harboring the gene fusion. Further studies are necessary to confirm this hypothesis.

Original languageEnglish (US)
Pages (from-to)1499-1506
Number of pages8
JournalModern Pathology
Volume23
Issue number11
DOIs
StatePublished - Nov 1 2010

Keywords

  • ERG rearrangement
  • peripheral zone
  • prostate cancer
  • transition zone

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'ERG rearrangement is present in a subset of transition zone prostatic tumors'. Together they form a unique fingerprint.

  • Cite this

    Falzarano, S. M., Navas, M., Simmerman, K., Klein, E. A., Rubin, M. A., Zhou, M., & Magi-Galluzzi, C. (2010). ERG rearrangement is present in a subset of transition zone prostatic tumors. Modern Pathology, 23(11), 1499-1506. https://doi.org/10.1038/modpathol.2010.150